InvestSMART

Optiscan Imaging Limited (ASX: OIL) - Announcements

Current share price for OIL : $0.160 0.005 (3.23%)+

ASX company news and announcements for Optiscan Imaging Limited (OIL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Optiscan Imaging Limited (OIL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Optiscan Imaging Limited (OIL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Optiscan Imaging Limited (OIL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$167 Change of Company Secretary 4 Feb 2025 8:20AM $0.165 $0.160 fallen by 3.03%
$167 Optiscan Initiates GI Study in Germany with First Prototype 3 Feb 2025 8:26AM $0.160 $0.160 fallen by 0%
$167 OIL December 2024 Quarterly Report and Appendix 4C 31 Jan 2025 8:52AM $0.160 $0.160 fallen by 0%
$167 Optiscan receives $1.775m R&D Tax Refund 31 Jan 2025 8:23AM $0.160 $0.160 fallen by 0%
$167 Change in substantial holding 6 Dec 2024 3:18PM $0.160 $0.160 fallen by 0%
$167 Results of Annual General Meeting 21 Nov 2024 2:06PM $0.160 $0.160 fallen by 0%
$167 OIL Managing Director's Presentation & Chair's Address 21 Nov 2024 11:02AM $0.170 $0.160 fallen by 5.88%
$167 Optiscan Signs Research Agreement with Minnesota Vet College 18 Nov 2024 12:59PM $0.170 $0.160 fallen by 5.88%
$167 Optiscan Signs Agreement with Monash to Progress GI Scope 4 Nov 2024 9:48AM $0.165 $0.160 fallen by 3.03%
$167 OIL September 2024 Quarterly Report and Appendix 4C 31 Oct 2024 1:24PM $0.160 $0.160 fallen by 0%
$167 Optiscan Participates in Major US Industry Events 28 Oct 2024 9:04AM $0.160 $0.160 fallen by 0%
$167 2024 AGM - Letter to Shareholders & Proxy Form 21 Oct 2024 3:35PM $0.160 $0.160 fallen by 0%
$167 Notice of Annual General Meeting/Proxy Form 21 Oct 2024 3:31PM $0.160 $0.160 fallen by 0%
$167 Annual General Meeting Date 7 Oct 2024 4:48PM $0.165 $0.160 fallen by 3.03%
$167 Appendix 4G & Corporate Governance Statement 30 Aug 2024 2:36PM $0.185 $0.160 fallen by 13.51%
$167 OIL 2024 Annual Report 30 Aug 2024 2:35PM $0.185 $0.160 fallen by 13.51%
$167 Appendix 4E Preliminary Final Report 30 Aug 2024 2:31PM $0.185 $0.160 fallen by 13.51%
$167 Optiscan Signs MOU with University of Minnesota 19 Aug 2024 9:16AM $0.205 $0.160 fallen by 21.95%
$167 OIL June 2024 Quarterly Report and Appendix 4C 31 Jul 2024 4:15PM $0.215 $0.160 fallen by 25.58%
$167 Optiscan Delivers Major Milestone in Telepathology Platform 29 Jul 2024 8:58AM $0.215 $0.160 fallen by 25.58%
$167 Optiscan Receives Ethical Clearance for Breast Cancer Study 15 Jul 2024 9:03AM $0.195 $0.160 fallen by 17.95%
$167 Notification regarding unquoted securities - OIL 12 Jul 2024 4:34PM $0.195 $0.160 fallen by 17.95%
$167 Optiscan 2024 Roadshow Presentation 1 Jul 2024 8:37AM $0.235 $0.160 fallen by 31.91%
$167 Optiscan Reveals InVue Imaging Device for Precision Surgery 4 Jun 2024 9:17AM $0.120 $0.160 risen by 33.33%
$167 Optiscan Webinar Investor Presentation 16 May 2024 10:26AM $0.120 $0.160 risen by 33.33%

76 - 100 of 633 results

Page 4 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.